Novavax Inc (NVAX) stock
NVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.72−0.24 (-3.02%)
Close on Nov 19, 2026Market cap $1.27BP/E –Yield –
Novavax shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Novavax's shares outstanding was 165M at Jun 30, 2026. For fiscal 2025 it was 173M, up 13.7% from the year before. Over ten years it grew 158.3% a year on average. The highest annual figure on record is 173M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 173M | +13.7% |
| FY2024 | Dec 31, 2024 | 152M | +51.0% |
| FY2023 | Dec 31, 2023 | 101M | +28.9% |
| FY2022 | Dec 31, 2022 | 78M | +5.1% |
| FY2021 | Dec 31, 2021 | 74M | +29.3% |
| FY2020 | Dec 31, 2020 | 58M | +138.8% |
| FY2019 | Dec 31, 2019 | 24M | +30.4% |
| FY2018 | Dec 31, 2018 | 18M | +26.3% |
| FY2017 | Dec 31, 2017 | 15M | +8.1% |
| FY2016 | Dec 31, 2016 | 14M | +103164.9% |
| FY2015 | Dec 31, 2015 | 0M | +16.1% |
| FY2014 | Dec 31, 2014 | 0M | -99.9% |
| FY2013 | Dec 31, 2013 | 8M | +128702.0% |
| FY2012 | Dec 31, 2012 | 0M | +15.9% |
| FY2011 | Dec 31, 2011 | 0M | +8.5% |
| FY2010 | Dec 31, 2010 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 165M | -7.1% |
| Q1 FY2026 | Mar 31, 2026 | 163M | -8.1% |
| Q4 FY2025 | Dec 31, 2025 | 188M | +17.2% |
| Q3 FY2025 | Sep 30, 2025 | 162M | +1.4% |
| Q2 FY2025 | Jun 30, 2025 | 177M | +6.8% |
| Q1 FY2025 | Mar 31, 2025 | 178M | +27.0% |
| Q4 FY2024 | Dec 31, 2024 | 160M | +29.3% |
| Q3 FY2024 | Sep 30, 2024 | 160M | +54.7% |
| Q2 FY2024 | Jun 30, 2024 | 166M | +59.4% |
| Q1 FY2024 | Mar 31, 2024 | 140M | +62.4% |
| Q4 FY2023 | Dec 31, 2023 | 124M | +55.2% |
| Q3 FY2023 | Sep 30, 2023 | 103M | +32.1% |
| Q2 FY2023 | Jun 30, 2023 | 104M | +33.2% |
| Q1 FY2023 | Mar 31, 2023 | 86M | +6.7% |
| Q4 FY2022 | Dec 31, 2022 | 80M | +5.5% |
| Q3 FY2022 | Sep 30, 2022 | 78M | +4.7% |
| Q2 FY2022 | Jun 30, 2022 | 78M | +5.4% |
| Q1 FY2022 | Mar 31, 2022 | 81M | +10.5% |
| Q4 FY2021 | Dec 31, 2021 | 76M | +15.0% |
| Q3 FY2021 | Sep 30, 2021 | 75M | +21.4% |
| Q2 FY2021 | Jun 30, 2021 | 74M | +26.4% |
| Q1 FY2021 | Mar 31, 2021 | 73M | +64.4% |
| Q4 FY2020 | Dec 31, 2020 | 66M | +134.0% |
| Q3 FY2020 | Sep 30, 2020 | 62M | +153.0% |
| Q2 FY2020 | Jun 30, 2020 | 59M | +149.7% |
| Q1 FY2020 | Mar 31, 2020 | 44M | +117.3% |
| Q4 FY2019 | Dec 31, 2019 | 28M | +46.7% |
| Q3 FY2019 | Sep 30, 2019 | 24M | +27.3% |
| Q2 FY2019 | Jun 30, 2019 | 23M | +24.9% |
| Q1 FY2019 | Mar 31, 2019 | 20M | +21.3% |
| Q4 FY2018 | Dec 31, 2018 | 19M | +21.2% |
| Q3 FY2018 | Sep 30, 2018 | 19M | +29.0% |
| Q2 FY2018 | Jun 30, 2018 | 19M | +32.6% |
| Q1 FY2018 | Mar 31, 2018 | 17M | +122801.7% |
| Q4 FY2017 | Dec 31, 2017 | 16M | +116604.4% |
| Q3 FY2017 | Sep 30, 2017 | 15M | – |
| Q2 FY2017 | Jun 30, 2017 | 14M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?